Invech Holdings Files Q3 2024 10-Q

Ticker: IVHI · Form: 10-Q · Filed: Oct 31, 2024 · CIK: 1009919

Invech Holdings, Inc. 10-Q Filing Summary
FieldDetail
CompanyInvech Holdings, Inc. (IVHI)
Form Type10-Q
Filed DateOct 31, 2024
Risk Levellow
Pages15
Reading Time19 min
Key Dollar Amounts$1,000, $0.001, $2,500,000 b, $35,000, $50,000
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, reporting

Related Tickers: IVHI

TL;DR

Invech Holdings (IVHI) filed its Q3 10-Q. Check financials.

AI Summary

Invech Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Amersin Life Sciences CORP, is incorporated in Nevada and operates in management consulting services. Key financial data points and preferred stock details are included in the filing.

Why It Matters

This filing provides investors with an update on Invech Holdings' financial performance and position as of the end of the third quarter of 2024.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing financial updates, not indicating immediate significant risk.

Key Numbers

  • 2024-09-30 — Period End Date (The 10-Q covers financial information up to this date.)
  • 2024-01-01 — Quarter Start Date (The filing covers the third quarter of 2024.)
  • 2023-12-31 — Previous Year End Date (Comparative financial data for the previous fiscal year end is referenced.)

Key Players & Entities

  • Invech Holdings, Inc. (company) — Filer of the 10-Q
  • Amersin Life Sciences CORP (company) — Former name of Invech Holdings, Inc.
  • 2024-09-30 (date) — Period of report for the 10-Q
  • 8742 (number) — Standard Industrial Classification code for Management Consulting Services

FAQ

What is the primary business of Invech Holdings, Inc.?

Invech Holdings, Inc. operates in the Services-Management Consulting Services sector, with a Standard Industrial Classification code of 8742.

What is the reporting period for this 10-Q filing?

The Conformed Period of Report for this 10-Q filing is September 30, 2024.

What were the former names of Invech Holdings, Inc.?

Invech Holdings, Inc. was formerly known as Amersin Life Sciences CORP, HUBEI PHARMACEUTICAL GROUP LTD, and PAN ASIA COMMUNICATIONS CORP.

In which state is Invech Holdings, Inc. incorporated?

Invech Holdings, Inc. is incorporated in Nevada (NV).

What is the fiscal year end for Invech Holdings, Inc.?

The fiscal year end for Invech Holdings, Inc. is December 31 (1231).

Filing Stats: 4,626 words · 19 min read · ~15 pages · Grade level 13.2 · Accepted 2024-10-31 11:45:52

Key Financial Figures

  • $1,000 — services, for total non-cash expense of $1,000. 8 NOTE 6 – RESTATEMENT Per ASC 25
  • $0.001 — ockholders' Deficit: Preferred stock, $0.001 par value; 5,000,000 shares authorized
  • $2,500,000 b — any was obligated to raise in excess of $2,500,000 by the private placement of the Company's
  • $35,000 — ent (HK) Ltd. for the purchase price of $35,000. The Custodian did not receive any addi
  • $50,000 — Logistic Inc. for the purchase price of $50,000. Robert Chin, sole officer and director
  • $45,000 — mpliance, LLC for the purchase price of $45,000. These shares represent the majority co

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION ITEM 1.

Financial Statements

Financial Statements Condensed Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 (Unaudited) 3 Condensed Statements of Operations for the Nine Months ended September 30, 2024 and 2023 (Unaudited) 4 Condensed Statements of Changes in Stockholders' Deficit for the Nine Months ended September 30, 2024 and 2023 (Unaudited) 5 Condensed Statements of Cash Flows for the Nine Months ended September 30, 2024 and 2023 (Unaudited) 6 Notes to the Condensed Financial Statements (Unaudited) 7 ITEM 2.

Management's Discussion And Analysis Of Financial Condition And Results Of Operations

Management's Discussion And Analysis Of Financial Condition And Results Of Operations 10 ITEM 3.

Quantitative And Qualitative Disclosures About Market Risk

Quantitative And Qualitative Disclosures About Market Risk 16 ITEM 4.

Controls And Procedures

Controls And Procedures 16

OTHER INFORMATION

PART II. OTHER INFORMATION ITEM 1.

Legal Proceedings

Legal Proceedings 18 ITEM 1A.

Risk Factors

Risk Factors 18 ITEM 2. Unregistered Sales Of Equity Securities And Use Of Proceeds 18 ITEM 3. Defaults Upon Senior Securities 18 ITEM 4. Mine Safety Disclosures 18 ITEM 5. Other Information 18 ITEM 6. Exhibits 18

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements INVECH HOLDINGS, INC . CONDENSED BALANCE SHEETS (Unaudited) September 30, December 31, 2024 2023 ASSETS (Restated) Current Assets: Cash $ – $ 7,000 Prepaid 3,150 – Total Assets $ 3,150 $ 7,000 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Due to a related party $ 78,214 $ 30,641 Due to a former related party 4,443 4,443 Accruals 5,391 5,391 Total Liabilities 88,048 40,475 Stockholders' Deficit: Preferred stock, $ 0.001 par value; 5,000,000 shares authorized – – Series A Preferred stock, $ 0.001 par value; 1,000,000 shares designated; 300,000 and 300,000 shares issued and outstanding, respectively 300 300 Common stock, $ 0.001 par value; 500,000,000 shares authorized, 10,521,335 and 10,521,335 shares issued and outstanding, respectively 10,521 10,521 Additional paid-in capital 202,294 202,294 Accumulated deficit ( 298,013 ) ( 246,590 ) Total Stockholders' Deficit ( 84,898 ) ( 33,475 ) Total Liabilities and Stockholders' Deficit $ 3,150 $ 7,000 The accompanying notes are an integral part of these unaudited financial statements. 3 INVECH HOLDINGS, INC . CONDENSED (Unaudited) For the Three Months Ended For the Nine Months Ended September 30, September 30, 2024 2023 2024 2023 Operating Expenses: General and administrative expenses $ 5,647 $ 6,188 $ 51,423 $ 29,434 Total operating expenses 5,647 6,188 51,423 29,434 Loss from operations ( 5,647 ) ( 6,188 ) ( 51,423 ) ( 29,434 ) Net Loss $ ( 5,647 ) $ ( 6,188 ) $ ( 51,423 ) $ ( 29,434 ) Loss per share– basic and diluted $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) Weighted average shares – basic and diluted 10,521,335 9,532,324 10,521,335 9,524,998 Accompanying notes are an integral part of these unaudited financial statements . 4 INVECH HOLDINGS, INC . CONDENSED FOR T

Management's Discussion and Analysis

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following management's discussion and analysis ("MD&A") should be read in conjunction with financial statements of Invech Holdings, Inc. for the three months ended September 30, 2024, and 2023, and the notes thereto. Safe Harbor for Forward-Looking Certain the development of the Company's business, the markets for the Company's products, anticipated capital expenditures, and the effects of completed and proposed acquisitions, and other statements contained herein regarding matters that are not historical facts, are forward-looking Because such statements include risks and uncertainties, actual results could differ materially from those expressed or implied by such forward-looking statements as set forth in this report, the Company's Annual Report on Form 10-K and other reports that the Company files with the Securities and Exchange Commission. Certain risks and uncertainties are wholly or partially outside the control of the Company and its management, including its ability to attract new clients; the continued success in servicing current clients; the effects of competition in new and existing markets; fluctuation in development and operating costs; brand awareness; availability and terms of capital; adverse publicity; acceptance of new product offerings; and changes in government regulation. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements which

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.